Industry: Service & Software
Published Date: 2025-03-12
Pages: 84 Pages
Report ld: 4646561
Request Sample
Customized Report
Gene Knockdown Stable Cell Line Service Market Size(US$)

CAGR 2025-2031
5.2%
Market Size,2031
USD 345
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Gene Knockdown Stable Cell Line Service was valued at US$ 243 million in the year 2024 and is projected to reach a revised size of US$ 345 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Gene Knockdown Stable Cell Line Service is a professional biomedical research service that aims to permanently knock out specific genes in cells through specific technical means, and this knockdown state can be stably maintained during multiple cell generations.
North American market for Gene Knockdown Stable Cell Line Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Gene Knockdown Stable Cell Line Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Gene Knockdown Stable Cell Line Service in Genomics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Gene Knockdown Stable Cell Line Service include AMSBIO, Aptagen, Aptamer Group, PORTON, Base Pair, Base Pair Biotechnologies, Cambio, CD Bioparticles, Creative Biolabs, Eurogentec, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gene Knockdown Stable Cell Line Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Knockdown Stable Cell Line Service.
The Gene Knockdown Stable Cell Line Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Knockdown Stable Cell Line Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Knockdown Stable Cell Line Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Knockdown Stable Cell Line Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Knockdown Stable Cell Line Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 RNA Interference
1.2.3 CRISPRs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gene Knockdown Stable Cell Line Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Genomics
1.3.3 Design Disease Models
1.3.4 Biopharmaceutical Research
1.3.5 Drug Discovery
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Knockdown Stable Cell Line Service Market Perspective (2020-2031)
2.2 Global Gene Knockdown Stable Cell Line Service Growth Trends by Region
2.2.1 Global Gene Knockdown Stable Cell Line Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Knockdown Stable Cell Line Service Historic Market Size by Region (2020-2025)
2.2.3 Gene Knockdown Stable Cell Line Service Forecasted Market Size by Region (2026-2031)
2.3 Gene Knockdown Stable Cell Line Service Market Dynamics
2.3.1 Gene Knockdown Stable Cell Line Service Industry Trends
2.3.2 Gene Knockdown Stable Cell Line Service Market Drivers
2.3.3 Gene Knockdown Stable Cell Line Service Market Challenges
2.3.4 Gene Knockdown Stable Cell Line Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Knockdown Stable Cell Line Service Players by Revenue
3.1.1 Global Top Gene Knockdown Stable Cell Line Service Players by Revenue (2020-2025)
3.1.2 Global Gene Knockdown Stable Cell Line Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Gene Knockdown Stable Cell Line Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Knockdown Stable Cell Line Service Revenue
3.4 Global Gene Knockdown Stable Cell Line Service Market Concentration Ratio
3.4.1 Global Gene Knockdown Stable Cell Line Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Knockdown Stable Cell Line Service Revenue in 2024
3.5 Global Key Players of Gene Knockdown Stable Cell Line Service Head office and Area Served
3.6 Global Key Players of Gene Knockdown Stable Cell Line Service, Product and Application
3.7 Global Key Players of Gene Knockdown Stable Cell Line Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Knockdown Stable Cell Line Service Breakdown Data by Type
4.1 Global Gene Knockdown Stable Cell Line Service Historic Market Size by Type (2020-2025)
4.2 Global Gene Knockdown Stable Cell Line Service Forecasted Market Size by Type (2026-2031)
5 Gene Knockdown Stable Cell Line Service Breakdown Data by Application
5.1 Global Gene Knockdown Stable Cell Line Service Historic Market Size by Application (2020-2025)
5.2 Global Gene Knockdown Stable Cell Line Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Knockdown Stable Cell Line Service Market Size (2020-2031)
6.2 North America Gene Knockdown Stable Cell Line Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Knockdown Stable Cell Line Service Market Size by Country (2020-2025)
6.4 North America Gene Knockdown Stable Cell Line Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Knockdown Stable Cell Line Service Market Size (2020-2031)
7.2 Europe Gene Knockdown Stable Cell Line Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Knockdown Stable Cell Line Service Market Size by Country (2020-2025)
7.4 Europe Gene Knockdown Stable Cell Line Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Knockdown Stable Cell Line Service Market Size (2020-2031)
8.2 Asia-Pacific Gene Knockdown Stable Cell Line Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Knockdown Stable Cell Line Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Knockdown Stable Cell Line Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Knockdown Stable Cell Line Service Market Size (2020-2031)
9.2 Latin America Gene Knockdown Stable Cell Line Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Knockdown Stable Cell Line Service Market Size by Country (2020-2025)
9.4 Latin America Gene Knockdown Stable Cell Line Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Knockdown Stable Cell Line Service Market Size (2020-2031)
10.2 Middle East & Africa Gene Knockdown Stable Cell Line Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Knockdown Stable Cell Line Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Knockdown Stable Cell Line Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AMSBIO
11.1.1 AMSBIO Company Details
11.1.2 AMSBIO Business Overview
11.1.3 AMSBIO Gene Knockdown Stable Cell Line Service Introduction
11.1.4 AMSBIO Revenue in Gene Knockdown Stable Cell Line Service Business (2020-2025)
11.1.5 AMSBIO Recent Development
11.2 Aptagen
11.2.1 Aptagen Company Details
11.2.2 Aptagen Business Overview
11.2.3 Aptagen Gene Knockdown Stable Cell Line Service Introduction
11.2.4 Aptagen Revenue in Gene Knockdown Stable Cell Line Service Business (2020-2025)
11.2.5 Aptagen Recent Development
11.3 Aptamer Group
11.3.1 Aptamer Group Company Details
11.3.2 Aptamer Group Business Overview
11.3.3 Aptamer Group Gene Knockdown Stable Cell Line Service Introduction
11.3.4 Aptamer Group Revenue in Gene Knockdown Stable Cell Line Service Business (2020-2025)
11.3.5 Aptamer Group Recent Development
11.4 PORTON
11.4.1 PORTON Company Details
11.4.2 PORTON Business Overview
11.4.3 PORTON Gene Knockdown Stable Cell Line Service Introduction
11.4.4 PORTON Revenue in Gene Knockdown Stable Cell Line Service Business (2020-2025)
11.4.5 PORTON Recent Development
11.5 Base Pair
11.5.1 Base Pair Company Details
11.5.2 Base Pair Business Overview
11.5.3 Base Pair Gene Knockdown Stable Cell Line Service Introduction
11.5.4 Base Pair Revenue in Gene Knockdown Stable Cell Line Service Business (2020-2025)
11.5.5 Base Pair Recent Development
11.6 Base Pair Biotechnologies
11.6.1 Base Pair Biotechnologies Company Details
11.6.2 Base Pair Biotechnologies Business Overview
11.6.3 Base Pair Biotechnologies Gene Knockdown Stable Cell Line Service Introduction
11.6.4 Base Pair Biotechnologies Revenue in Gene Knockdown Stable Cell Line Service Business (2020-2025)
11.6.5 Base Pair Biotechnologies Recent Development
11.7 Cambio
11.7.1 Cambio Company Details
11.7.2 Cambio Business Overview
11.7.3 Cambio Gene Knockdown Stable Cell Line Service Introduction
11.7.4 Cambio Revenue in Gene Knockdown Stable Cell Line Service Business (2020-2025)
11.7.5 Cambio Recent Development
11.8 CD Bioparticles
11.8.1 CD Bioparticles Company Details
11.8.2 CD Bioparticles Business Overview
11.8.3 CD Bioparticles Gene Knockdown Stable Cell Line Service Introduction
11.8.4 CD Bioparticles Revenue in Gene Knockdown Stable Cell Line Service Business (2020-2025)
11.8.5 CD Bioparticles Recent Development
11.9 Creative Biolabs
11.9.1 Creative Biolabs Company Details
11.9.2 Creative Biolabs Business Overview
11.9.3 Creative Biolabs Gene Knockdown Stable Cell Line Service Introduction
11.9.4 Creative Biolabs Revenue in Gene Knockdown Stable Cell Line Service Business (2020-2025)
11.9.5 Creative Biolabs Recent Development
11.10 Eurogentec
11.10.1 Eurogentec Company Details
11.10.2 Eurogentec Business Overview
11.10.3 Eurogentec Gene Knockdown Stable Cell Line Service Introduction
11.10.4 Eurogentec Revenue in Gene Knockdown Stable Cell Line Service Business (2020-2025)
11.10.5 Eurogentec Recent Development
11.11 Novaptech
11.11.1 Novaptech Company Details
11.11.2 Novaptech Business Overview
11.11.3 Novaptech Gene Knockdown Stable Cell Line Service Introduction
11.11.4 Novaptech Revenue in Gene Knockdown Stable Cell Line Service Business (2020-2025)
11.11.5 Novaptech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Gene Knockdown Stable Cell Line Service market is projected to grow from US$ 254 million in 2025 to US$ 361 million by 2032, at a CAGR of 5.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-25
Pages: 131
USD 4900.00
(Single User License)
The global Gene Knockdown Stable Cell Line Service market size was US$ 254 million in 2025 and is forecast to reach a readjusted size of US$ 361 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 92
USD 4250.00
(Single User License)
The global Gene Knockdown Stable Cell Line Service market was valued at US$ 254 million in 2025 and is anticipated to reach US$ 361 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 111
USD 2900.00
(Single User License)
The global market for Gene Knockdown Stable Cell Line Service was estimated to be worth US$ 254 million in 2025 and is projected to reach US$ 361 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 101
USD 3950.00
(Single User License)
The global Gene Knockdown Stable Cell Line Service market size was US$ 243 million in 2024 and is forecast to a readjusted size of US$ 345 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 95
USD 4250.00
(Single User License)
The global Gene Knockdown Stable Cell Line Service market is projected to grow from US$ 243 million in 2024 to US$ 345 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-01
Pages: 134
USD 4900.00
(Single User License)
The global market for Gene Knockdown Stable Cell Line Service was estimated to be worth US$ 243 million in 2024 and is forecast to a readjusted size of US$ 345 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 112
USD 3950.00
(Single User License)
Valued at US$ 243 million in 2024, the global Gene Knockdown Stable Cell Line Service market is forecast to reach US$ 329 million by 2030, at a CAGR of 5.2% during the forecast period.
Published Date: 2024-12-04
Pages: 139
USD 4900.00
(Single User License)
The global Gene Knockdown Stable Cell Line Service revenue was US$ 218 million in 2023 and is forecast to a readjusted size of US$ 329 million by 2030 with a CAGR of 5.2% during the review period (2024-2030).
Published Date: 2024-12-04
Pages: 120
USD 4350.00
(Single User License)
The global market for Gene Knockdown Stable Cell Line Service was estimated to be worth US$ 218 million in 2023 and is forecast to a readjusted size of US$ 329 million by 2030 with a CAGR of 5.2% during the forecast period 2024-2030.
Published Date: 2024-12-04
Pages: 104
USD 3950.00
(Single User License)
The global Gene Knockdown Stable Cell Line Service market is projected to grow from US$ 254 million in 2025 to US$ 361 million by 2032, at a CAGR of 5.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-25
Pages: 131
The global Gene Knockdown Stable Cell Line Service market size was US$ 254 million in 2025 and is forecast to reach a readjusted size of US$ 361 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 92
The global Gene Knockdown Stable Cell Line Service market was valued at US$ 254 million in 2025 and is anticipated to reach US$ 361 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 111
The global market for Gene Knockdown Stable Cell Line Service was estimated to be worth US$ 254 million in 2025 and is projected to reach US$ 361 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 101
The global Gene Knockdown Stable Cell Line Service market size was US$ 243 million in 2024 and is forecast to a readjusted size of US$ 345 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 95
The global Gene Knockdown Stable Cell Line Service market is projected to grow from US$ 243 million in 2024 to US$ 345 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-01
Pages: 134
The global market for Gene Knockdown Stable Cell Line Service was estimated to be worth US$ 243 million in 2024 and is forecast to a readjusted size of US$ 345 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 112
Valued at US$ 243 million in 2024, the global Gene Knockdown Stable Cell Line Service market is forecast to reach US$ 329 million by 2030, at a CAGR of 5.2% during the forecast period.
Published: 2024-12-04
Pages: 139
The global Gene Knockdown Stable Cell Line Service revenue was US$ 218 million in 2023 and is forecast to a readjusted size of US$ 329 million by 2030 with a CAGR of 5.2% during the review period (2024-2030).
Published: 2024-12-04
Pages: 120
The global market for Gene Knockdown Stable Cell Line Service was estimated to be worth US$ 218 million in 2023 and is forecast to a readjusted size of US$ 329 million by 2030 with a CAGR of 5.2% during the forecast period 2024-2030.
Published: 2024-12-04
Pages: 104
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now